Effects of Two Doses of Thylakoids on OGTT
NCT02702245 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21
Last updated 2017-05-15
Summary
This cross-over intervention study aims to investigate the effect of two doses of thylakoids to an oral glucose tolerance test (OGTT) on glucose and insulin homeostasis as well as appetite regulating hormones in healthy volunteers.
Conditions
- Glucose Intolerance
Interventions
- DIETARY_SUPPLEMENT
-
Experimental: Thylakoids 5 g
75 g pure glucose + 5 g chloroplast membranes from spinach leaves in a dried powder.
- DIETARY_SUPPLEMENT
-
Experimental: Thylakoids 10 g
75 g pure glucose + 10 g chloroplast membranes from spinach leaves in a dried powder.
- OTHER
-
Placebo Comparator: Control
75 g pure glucose.
Sponsors & Collaborators
-
Lund University
collaborator OTHER -
Region Skane
lead OTHER
Principal Investigators
-
Eva-Lena Stenblom, M.D. · Lund University, Region Skane
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2016-03-31
- Completion
- 2017-03-31
More Related Trials
-
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus
NCT01919684 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects
NCT03139305 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
The Separate and Combined Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Subjects With and Without Type 1 Diabetes
NCT06881472 ·Status: COMPLETED ·Phase: NA
-
Effect of Bile Acids on GLP-1 Secretion
NCT01666223 ·Status: COMPLETED ·Phase: NA
-
Effects of Oral GLP-1 on Glucose Homeostasis and Appetite Profile in Healthy Male Subjects
NCT00822003 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection.
NCT02077348 ·Status: COMPLETED ·Phase: NA
-
Safety Study of Repeated Doses of Glucagon on Animal Starch in the Liver
NCT01986231 ·Status: COMPLETED ·Phase: NA
-
Hepatic Metabolic Changes in Response to Glucagon Infusion
NCT03526445 ·Status: COMPLETED ·Phase: NA
-
Effects of Oral vs Intravenous Glucose Administration on Novel Candidates of Energy Regulation
NCT04888325 ·Status: COMPLETED ·Phase: NA
-
Effects of Prebiotics on GLP-1 in Type 2 Diabetes
NCT02569684 ·Status: COMPLETED ·Phase: NA
-
The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction
NCT05499702 ·Status: RECRUITING ·Phase: PHASE2
-
Glucagon Like Peptide-1 in Remote Ischemic Conditioning
NCT02746757 ·Status: COMPLETED ·Phase: NA
-
Diet Oil Induced Stimulation of GLP-1
NCT01453842 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation
NCT02672839 ·Status: COMPLETED ·Phase: PHASE1
-
The Glucagonotropic Effect of Amino Acids in Humans
NCT05954923 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 Diabetes
NCT04956263 ·Status: COMPLETED ·Phase: PHASE2
-
Pathogenesis of Youth Onset Type 2 Diabetes and Prediabetes
NCT03195400 ·Status: COMPLETED
-
The Role of Glucose-Dependent Insulinotropic Polypeptide in the Pathological Glucose Homeostasis Of Type 1 Diabetes
NCT03734718 ·Status: COMPLETED ·Phase: NA
-
The Effect of GIP, GLP-1 and GLP-2 in Individuals With Genetically Altered Receptor Function
NCT06194955 ·Status: COMPLETED ·Phase: NA
-
Glucagon Responses During Oral- and iv Glucose in Patients With Type 1 Diabetes
NCT00704795 ·Status: UNKNOWN
-
Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)
NCT01373450 ·Status: COMPLETED ·Phase: PHASE1
-
A Glucometabolic Evaluation of Patients With Idiopathic Ketotic Hypoglycemia
NCT05310292 ·Status: UNKNOWN ·Phase: NA
-
Carnitine Levels and Carnitine Supplementation in Type I Diabetes
NCT00351234 ·Status: COMPLETED
-
The Impact of Subcutaneous Glucagon Before, During and After Exercise a Study in Patients With Type 1 Diabetes Mellitus
NCT02882737 ·Status: COMPLETED ·Phase: NA
-
Insulin Sensitivity and Metabolomics During Oral Administration of Glucose and Graded Intravenous Infusion
NCT03223129 ·Status: COMPLETED ·Phase: NA